ATE335818T1 - Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung - Google Patents

Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung

Info

Publication number
ATE335818T1
ATE335818T1 AT96943306T AT96943306T ATE335818T1 AT E335818 T1 ATE335818 T1 AT E335818T1 AT 96943306 T AT96943306 T AT 96943306T AT 96943306 T AT96943306 T AT 96943306T AT E335818 T1 ATE335818 T1 AT E335818T1
Authority
AT
Austria
Prior art keywords
protein
coupled receptor
ligand polypeptide
hypophysis
production
Prior art date
Application number
AT96943306T
Other languages
English (en)
Inventor
Shuji Hinuma
Yugo Habata
Yuji Kawamata
Masaki Hosoya
Ryo Fujii
Shoji Fukusumi
Chieko Kitada
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE335818T1 publication Critical patent/ATE335818T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
AT96943306T 1995-12-28 1996-12-26 Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung ATE335818T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP34337195 1995-12-28
JP5941996 1996-03-15
JP21180596 1996-08-12
JP24657396 1996-09-18

Publications (1)

Publication Number Publication Date
ATE335818T1 true ATE335818T1 (de) 2006-09-15

Family

ID=27463762

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943306T ATE335818T1 (de) 1995-12-28 1996-12-26 Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung

Country Status (8)

Country Link
US (3) US6228984B1 (de)
EP (1) EP0870020B1 (de)
CN (1) CN1149286C (de)
AT (1) ATE335818T1 (de)
AU (1) AU1208497A (de)
CA (1) CA2239299A1 (de)
DE (1) DE69636437T2 (de)
WO (1) WO1997024436A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69636437T2 (de) * 1995-12-28 2007-03-15 Takeda Pharmaceutical Co. Ltd. Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung
WO1998049295A1 (en) * 1997-04-28 1998-11-05 Takeda Chemical Industries, Ltd. Ligand polypeptide for the g protein-coupled receptor from human pituitary glands
EP1001989A1 (de) * 1997-06-23 2000-05-24 Takeda Chemical Industries, Ltd. Prolaktin sekretionsmodulator
EP0887417A3 (de) * 1997-06-27 1999-01-13 Takeda Chemical Industries, Ltd. Verfahren zur Herstellung von einem 19P2-Liganden mittels Spaltung eines diesen Liganden enthaltenden Fusionsproteins
US20030006192A1 (en) * 1998-02-23 2003-01-09 Irving Wainer Immobilized G-protein coupled receptors on liquid chromatography stationary phases and use thereof for on-line screening
DE69942580D1 (de) 1998-05-21 2010-08-26 Takeda Pharmaceutical Antikörper und ihre verwendung
AU6005099A (en) * 1998-10-08 2000-04-26 Takeda Chemical Industries Ltd. Novel g protein-coupled receptor protein and dna thereof
US7192723B2 (en) 1998-11-13 2007-03-20 Takeda Pharmaceutical Company Limited G protein-coupled receptor protein, its DNA and ligand thereof
WO2000029441A1 (fr) * 1998-11-13 2000-05-25 Takeda Chemical Industries, Ltd. Nouvelle proteine receptrice couplee a la proteine g, son adn et son ligand
JP2000191696A (ja) * 1998-12-25 2000-07-11 Takeda Chem Ind Ltd ペプチドの用途
WO2001009182A1 (en) * 1999-08-03 2001-02-08 Oy Juvantia Pharma Ltd. Prolactin-releasing peptide and method for regulating autonomic functions and treating pain
AU6727900A (en) * 1999-08-27 2001-03-26 Takeda Chemical Industries Ltd. Novel g protein-coupled receptor protein and dna thereof
WO2001016298A1 (en) * 1999-08-31 2001-03-08 Smithkline Beecham Corporation Cloning of mouse gpr10 receptor
WO2001035984A1 (en) * 1999-11-18 2001-05-25 Takeda Chemical Industries, Ltd. Use of peptide
EP1262190A4 (de) * 2000-03-06 2004-03-17 Takeda Chemical Industries Ltd Rfrp enthaltend prolaktin sekretion regulator
US6884596B2 (en) 2000-04-28 2005-04-26 The Regents Of The University Of California Screening and therapeutic methods for promoting wakefulness and sleep
US6383764B1 (en) 2000-04-28 2002-05-07 The Regents Of The University Of California Methods of identifying compounds for controlling absence seizures in a mammal relating to prolactin-releasing peptide(PrRP)
JP2003252801A (ja) * 2002-02-27 2003-09-10 Japan Science & Technology Corp 下垂体特異的遺伝子の使用法
WO2003080099A2 (en) * 2002-03-26 2003-10-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10)
US7611832B2 (en) * 2002-08-01 2009-11-03 Arena Pharmaceuticals, Inc. Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
BRPI0410792B8 (pt) * 2003-05-29 2021-05-25 New River Pharmaceuticals Inc compostos de anfetamina resistentes à dependencia
WO2005041998A1 (en) 2003-10-02 2005-05-12 Ali Sadat M Peptide for promoting healing of fractures
JPWO2006030956A1 (ja) * 2004-09-15 2008-05-15 武田薬品工業株式会社 ＰｒＲＰおよびその受容体の新規用途
CH714402A1 (fr) * 2017-12-04 2019-06-14 Fond Luc Montagnier Procédé de détection de la présence d'un élément biochimique.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284746A (en) * 1990-02-08 1994-02-08 Zymogenetics, Inc. Methods of producing hybrid G protein-coupled receptors
IT1252444B (it) * 1990-09-07 1995-06-16 Enichem Spa Metodo per l'identificazione e/o l'isolamento di geni che codificano per recettori di membrana.
US5279957A (en) * 1992-04-30 1994-01-18 Washington University cDNA encoding human phospholipase A2 polypeptide
US5556744A (en) * 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
US5474766A (en) * 1992-12-18 1995-12-12 Washington University Methods and compositions for inhibition of hepatic clearance of tissue-type plasminogen activator
EP0804575A1 (de) * 1994-08-11 1997-11-05 Takeda Chemical Industries, Ltd. G-protein gekoppelte rezeptoren, verfahren zur herstellung und anwendung
US5534699A (en) * 1995-07-26 1996-07-09 National Electrostatics Corp. Device for separating and recombining charged particle beams
DE69636437T2 (de) * 1995-12-28 2007-03-15 Takeda Pharmaceutical Co. Ltd. Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung

Also Published As

Publication number Publication date
EP0870020B1 (de) 2006-08-09
CN1149286C (zh) 2004-05-12
DE69636437T2 (de) 2007-03-15
WO1997024436A3 (en) 1997-09-12
US6794491B1 (en) 2004-09-21
AU1208497A (en) 1997-07-28
DE69636437D1 (de) 2006-09-21
CN1207126A (zh) 1999-02-03
US20050170461A1 (en) 2005-08-04
WO1997024436A2 (en) 1997-07-10
EP0870020A2 (de) 1998-10-14
US6228984B1 (en) 2001-05-08
CA2239299A1 (en) 1997-07-10

Similar Documents

Publication Publication Date Title
ATE335818T1 (de) Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung
Groebe et al. Determinants involved in the affinity of α-conotoxins GI and SI for the muscle subtype of nicotinic acetylcholine receptors
ATE253111T1 (de) Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung
DE69841140D1 (de) Interleukin-17 rezeptor-ähnliches protein
DK1012274T3 (da) Dödsdomæneholdig receptor-4 (DR4: dödsreceptor 4), medlem af TNF-receptorsuperfamilien og som binder til TRAIL (Apo-2L)
ATE365796T1 (de) Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
ES2129622T3 (es) Receptores para interleuquina-10 de mamifero.
DE69430130D1 (de) Polypeptide von der semaphorin-genfamilie
NO20000934L (no) Adipocyttspesifikke proteinhomologer
NO2010021I1 (no) Denosumab
BR9814335A (pt) Proteìna, exceto as existentes ao natural, polinucleotìdeo substancialmente puro, anticorpo elaborado por um processo que compreende a etapa de injetar uma preparação farmaceuticamente aceitável, vetor para expressar o drr-1 de rato, vetor, célula hospedeira drr-1 de rato, drr-1 de ser humano, drr-2 de ser humano, drr-3 de ser humano, drr-4 de ser humano, drr-5 de ser humano, drr-6 de ser humano recombinantes, e, processo para ensaiar um composto de teste quanto à sua capacidade para ligar-se a ou para ativar um receptor especìfico de gânglios da raiz dorsal ligado à proteìna g (drr)
WO1998031806A3 (en) Fc receptors and polypeptides
BR9507618A (pt) Frações polipeptidicas solúveis da proteína lag-3 processo de produção composição terapêutica anticorpos anti-idiotipo
ATE142645T1 (de) Rezeptoren für wachstumshormone
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
DK0746332T4 (da) DNA, som koder for et humant neuropeptid Y/peptid YY/pankreas-polypeptidreceptor (Y4), samt anvendelser deraf
ATE203566T1 (de) Protein-g-gekoppelte glutaminsäure-rezeptoren
ES2085993T3 (es) Proteina asociada a la pancreatitis aguda, medios para el diagnostico de la pancreatitis aguda.
ATE327328T1 (de) Adipozyten-spezifische protein homologe
EP0628054A4 (de) Car-rezeptoren und verwandte moleküle und entsprechende methoden.
ATE360643T1 (de) Humanes cyr61
DE69735716D1 (de) Kappa/mu ähnliche proteintyrosinphosphatase, proteintyrosinphosphatase lambda
EP0789076A3 (de) Protein-G-gekoppelter Rezeptorproteine, deren Herstellung und Verwendung
DE69426076D1 (de) Gereinigte flt3 liganden von saeugentieren, agonisten und antagonisten davon
ES2129120T3 (es) Un receptor de celulas t humanas de la familia de receptores acoplados a la proteina g.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties